CASIN Real Estate Development Group (000838.SZ) signed the "Restructuring Investment Agreement" with pre-restructuring investors, and the stock has resumed trading.
*ST Development (000838.SZ) announced that on August 7, 2026, the company signed the Restructuring Investment Agreement of Financial Trust Real Estate Development Group Co., Ltd. with the leading investor Tianjin Jingxing New Energy Enterprise Management Consulting Co., Ltd. (abbreviated as "Tianjin Jingxing") and the Gongqingcheng Jingxing New Energy Industry Investment Partnership (Limited Partnership) (abbreviated as "Gongqingcheng Jingxing"). The company's stock will resume trading on August 10, 2026 (Monday) at the market opening.
CASIN Real Estate Development Group (000838.SZ) announced that on August 7, 2026, the company signed the "Restructuring Investment Agreement of Caixin Real Estate Development Group Co., Ltd." with Tianjin Jingxing New Energy Enterprise Management Consulting Co., Ltd. (referred to as "Tianjin Jingxing") and Gongqingcheng Jingxing New Energy Industry Investment Partnership (Limited Partnership) (referred to as "Gongqingcheng Jingxing"). The company's shares will resume trading on August 10, 2026 (Monday) at market open.
Although the "Restructuring Investment Agreement" has been signed, there may still be risks of the agreement being terminated, rescinded, declared invalid, or unable to be performed.
Related Articles
Sealand: Air passenger transport is expected to stabilize and recover, and industry profitability may welcome improvement.
HK Stock Market Move | GENFLEET-B (02595) rose nearly 4% as GFH375 entered a Phase III clinical trial for the registration of monotherapy for non-small cell lung cancer in China.
HK Stock Market Move | WESTCHINACEMENT (02233) rose more than 10% during the session, expecting a net profit of up to 412 million yuan in the first half of the year, with overseas earnings growing against the trend.
Sealand: Air passenger transport is expected to stabilize and recover, and industry profitability may welcome improvement.
HK Stock Market Move | GENFLEET-B (02595) rose nearly 4% as GFH375 entered a Phase III clinical trial for the registration of monotherapy for non-small cell lung cancer in China.
HK Stock Market Move | WESTCHINACEMENT (02233) rose more than 10% during the session, expecting a net profit of up to 412 million yuan in the first half of the year, with overseas earnings growing against the trend.
RECOMMEND
